These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 36035237)

  • 1. Insights from Surgically treated Post Covid Acute Invasive Fungal Rhino-Orbital sinusitis in Chandrapur Study (SPAROS): A Population Based study of Coronavirus Associated Mucormycosis (CAM) characteristics in India.
    Kasatwar A; Shukla R; Rathod N; Nandanwar J; Mishra D; Dhobley A
    IJID Reg; 2022 Dec; 5():21-29. PubMed ID: 36035237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicenter Epidemiologic Study of Coronavirus Disease-Associated Mucormycosis, India.
    Patel A; Agarwal R; Rudramurthy SM; Shevkani M; Xess I; Sharma R; Savio J; Sethuraman N; Madan S; Shastri P; Thangaraju D; Marak R; Tadepalli K; Savaj P; Sunavala A; Gupta N; Singhal T; Muthu V; Chakrabarti A;
    Emerg Infect Dis; 2021 Sep; 27(9):2349-2359. PubMed ID: 34087089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 Associated Mucormycosis.
    Tazeem S; Nagaraju A; Begum H; Tommi JA; Sudarshan Reddy L; Vijay Kumar M
    Indian J Otolaryngol Head Neck Surg; 2023 Jun; 75(4):1-9. PubMed ID: 37362123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Serum Iron Studies in COVID Associated Mucormycosis with Stage of the Disease.
    Rao C; R M
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19-Associated mucormycosis: Case series from a tertiary care hospital in South India.
    Rashbi K S; Ali TMF; P N D; C K S; Payyappilly RJ
    Access Microbiol; 2022 Aug; 4(6):acmi000360. PubMed ID: 36004359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rising Incidence of Post Covid Rhinocerebral Mucormycosis: An Otolaryngologists Prospective.
    Sahni D; Singh P; Kaur R; Aggarwal S; Kaur A
    Indian J Otolaryngol Head Neck Surg; 2023 May; 75(4):1-9. PubMed ID: 37362131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coronavirus disease-associated mucormycosis (CAM): A case control study during the outbreak in India.
    Wasiq M; K R; Gn A
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors and outcomes of COVID associated mucormycosis in kidney transplant recipients.
    Bansal SB; Rana A; Babras M; Yadav D; Jha P; Jain M; Sethi SK
    Transpl Infect Dis; 2022 Apr; 24(2):e13777. PubMed ID: 34932870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-reactive Protein Kinetics During In-Patient Treatment of COVID-19-Associated Rhino-Orbito-Cerebral Mucormycosis: A Retrospective Cohort Study in a Tertiary Hospital in Central India.
    B H S; Bidkar V; Prathipati K; Dabhekar S; Selvaraj K; G D
    Cureus; 2024 Apr; 16(4):e59007. PubMed ID: 38800245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology, clinical presentation and management of COVID-19 associated mucormycosis: A single centre experience from Pune, Western India.
    Dravid A; Kashiva R; Khan Z; Bande B; Memon D; Kodre A; Mane M; Pawar V; Patil D; Kalyani S; Raut P; Bapte M; Saldanha C; Chandak D; Patil T; Reddy S; Bhayani K; Suresh L; Dillibabu V; Srivastava S; Khandelwal S; More S; Shakeel A; Pawar M; Nande P; Harshe A; Kadam S; Hallikar S; Kamal N; Andrabi D; Bodhale S; Raut A; Chandrashekhar S; Raman C; Mahajan U; Joshi G; Mane D
    Mycoses; 2022 May; 65(5):526-540. PubMed ID: 35212032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology and Pathophysiology of COVID-19-Associated Mucormycosis: India Versus the Rest of the World.
    Muthu V; Rudramurthy SM; Chakrabarti A; Agarwal R
    Mycopathologia; 2021 Dec; 186(6):739-754. PubMed ID: 34414555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19-associated mucormycosis in India: Why such an outbreak?
    Pasquier G
    J Mycol Med; 2023 Aug; 33(3):101393. PubMed ID: 37182234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19-associated mucormycosis of head-and-neck region: A systematic review.
    Kamat M; Datar U; Byakodi S; Kamat S; Vimal Kumar V
    J Clin Transl Res; 2022 Feb; 8(1):31-42. PubMed ID: 35187287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Features and Mortality of COVID-19-Associated Mucormycosis: A Systematic Review and Meta-Analysis.
    Watanabe A; So M; Mitaka H; Ishisaka Y; Takagi H; Inokuchi R; Iwagami M; Kuno T
    Mycopathologia; 2022 Jun; 187(2-3):271-289. PubMed ID: 35312945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19 associated multisystemic mucormycosis from India: a multicentric retrospective study on clinical profile, predisposing factors, cumulative mortality and factors affecting outcome.
    Sahu M; Shah M; Mallela VR; Kola VR; Boorugu HK; Punjani AAR; Kumar RV; Kumar S; Manusrut M; Kumar SCR; Rathod R; Babu DM; Gonuguntla HK; Yedlapati GK; Mallu GR; Reddy YS; Reddy VV; Alwala S; Bongu VK; Kamalesh A; Kumar RNK; Jaishetwar GS; Bagapally RS; Srinivas JS; Balasubramaniam A; Rajagopalan BK; Pullikanti B; Prakasham SP; Nimmala P; Nagaraju B; Sahoo PR;
    Infection; 2023 Apr; 51(2):407-416. PubMed ID: 35922704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outbreak of Mucormycosis in Coronavirus Disease Patients, Pune, India.
    Joshi S; Telang R; Tambe M; Havaldar R; Sane M; Shaikh A; Roy C; Yathati K; Sonawale S; Borkar R; Magar R; Bhitkar H; Shitole S; Nakate L; Kudrimoti J; Mave V
    Emerg Infect Dis; 2022 Jan; 28(1):1-8. PubMed ID: 34586055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19-associated mucormycosis: An updated systematic review of literature.
    Pal R; Singh B; Bhadada SK; Banerjee M; Bhogal RS; Hage N; Kumar A
    Mycoses; 2021 Dec; 64(12):1452-1459. PubMed ID: 34133798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rhino-orbital mucormycosis following COVID-19 in previously non-diabetic, immunocompetent patients.
    Nair AG; Adulkar NG; D'Cunha L; Rao PR; Bradoo RA; Bapaye MM; Kothari A; Dave TV; Shinde CA
    Orbit; 2021 Dec; 40(6):499-504. PubMed ID: 34338124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19 Associated Mucormycosis (CAM): A Single Hospital-Based Study.
    Vijapur MM; Kattimani V; Varsha VK; Girish HC; Kamat M; Ram B
    J Oral Maxillofac Pathol; 2022; 26(2):147-155. PubMed ID: 35968169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors and clinical presentation of rhino-orbital mucormycosis: Lesson learnt during Covid pandemic.
    Kusumesh R; Singh V; Sinha S; Ali MS; Mishra SK; Ambasta A; Prakash V; Sinha P; Sinha BP; Priyadarshi RN
    J Family Med Prim Care; 2024 Apr; 13(4):1354-1361. PubMed ID: 38827672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.